Administration of high doses of respiratory syncytial virus immune globulin is a safe and effective means of preventing lower respiratory tract infection in infants and young children at high risk for this disease.

The respiratory rates/minute of 97 children were monitored every 10-15 minutes over one hour, by an observer and by pneumogram, at which times two 30 second and one 60 second counts were obtained. (1) To determine the accuracy of respiratory rate counting by comparing observer counts with those obtained from an electronic pneumogram for 30 second and 60 second counting intervals.(2) To determine the effect of (i) the age, (ii) the illness, and (iii) the state of the child (that is, whether the child was sleeping, calm and awake, feeding, or agitated) on the accuracy of counting.(3) To determine the natural variability in the respiratory rate over one hour.(4) To determine how many attempts at obtaining a respiratory rate resulted in failures and identify the reasons for failures.Subjects and methods Subjects were prospectively enrolled in the study and consisted of children less than 5 years of age seen at three locations within the 1199 on 11 May 2018 by guest. Protected by copyright.

No abstract

RSVIG treatment was safe but not efficacious in the treatment of children with bronchopulmonary dysplasia, congenital heart disease, or premature gestation who were hospitalized with RSV LRI.